Actinogen Medical Ltd (ACW)

Currency in AUD
0.023
-0.001(-4.17%)
Closed·
ACW Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ACW is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0230.024
52 wk Range
0.0190.055
Key Statistics
Bid/Ask
0.023 / 0.025
Prev. Close
0.024
Open
0.024
Day's Range
0.023-0.024
52 wk Range
0.019-0.055
Volume
1.31M
Average Volume (3m)
7.36M
1-Year Change
-69.74%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ACW Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Actinogen Medical Ltd Company Profile

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials, that achieves target engagement in the brain for the treatment of Alzheimer’s disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.

Compare ACW to Peers and Sector

Metrics to compare
ACW
Peers
Sector
Relationship
P/E Ratio
−7.9x−4.6x−0.5x
PEG Ratio
−0.15−0.020.00
Price/Book
3.2x2.6x2.6x
Price / LTM Sales
8.5x13.7x3.3x
Upside (Analyst Target)
-284.8%43.4%
Fair Value Upside
Unlock−4.4%7.1%Unlock

Earnings

Latest Release
May 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ACW Income Statement

FAQ

What Stock Exchange Does Actinogen Medical Trade On?

Actinogen Medical is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Actinogen Medical?

The stock symbol for Actinogen Medical is "ACW."

What Is the Actinogen Medical Market Cap?

As of today, Actinogen Medical market cap is 76.25M.

What Is Actinogen Medical's Earnings Per Share (TTM)?

The Actinogen Medical EPS (TTM) is -0.00.

When Is the Next Actinogen Medical Earnings Date?

Actinogen Medical will release its next earnings report on 26 Aug 2025.

From a Technical Analysis Perspective, Is ACW a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Actinogen Medical Stock Split?

Actinogen Medical has split 4 times.

How Many Employees Does Actinogen Medical Have?

Actinogen Medical has 6 employees.

What is the current trading status of Actinogen Medical (ACW)?

As of 08 Aug 2025, Actinogen Medical (ACW) is trading at a price of 0.02, with a previous close of 0.02. The stock has fluctuated within a day range of 0.02 to 0.02, while its 52-week range spans from 0.02 to 0.06.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.